Nervomatrix raises $3.5 million in venture funding - MarketLine Financial Deals

Nervomatrix raises $3.5 million in venture funding

Nervomatrix raises $3.5 million in venture funding - MarketLine Financial Deals
Nervomatrix raises $3.5 million in venture funding
Published Sep 25, 2011
2 pages — Published Sep 25, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Nervomatrix, Ltd., an Israel-based developer of non-invasive drug-free pain relief products, has secured $3.5 million.

  
Source:
Document ID
MA81180_110927
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Nervomatrix raises $3.5 million in venture funding" Sep 25, 2011. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Nervomatrix-raises-3-5-million-in-venture-funding-2052-69438>
  
APA:
MarketLine Financial Deals. (2011). Nervomatrix raises $3.5 million in venture funding Sep 25, 2011. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Nervomatrix-raises-3-5-million-in-venture-funding-2052-69438>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.